Prism Peptides
AOD 9604
AOD 9604
Couldn't load pickup availability
🔴 IMPORTANT: Read Before Proceeding With Dosing
AOD-9604 (Anti-Obesity Drug 9604)
AOD-9604 is a modified fragment of human growth hormone (hGH) developed to support fat loss without the muscle-building effects, insulin changes, or side effects associated with full-length hGH.
Where GLP-1 agonists primarily suppress appetite and regulate insulin, AOD-9604 directly targets stored body fat:
-
Stimulates lipolysis (fat breakdown)
-
Inhibits lipogenesis (formation of new fat cells)
-
Blocks conversion of carbs into fat
-
Targets stubborn adipose reserves
This makes AOD-9604 an effective companion to GLP-1s for plateaus or for users who want fat-loss without appetite suppression.
⚙️ Mechanism of Action
AOD-9604 contains the TYR (Tyramine) portion of hGH responsible for fat-burning effects.
It activates lipid metabolism pathways without affecting insulin or growth pathways.
| Function | Effect | Outcome |
|---|---|---|
| Lipolysis stimulation | Breaks down stored fat | Fat mobilization |
| Lipogenesis inhibition | Blocks new fat cell formation | Reduced fat accumulation |
| Joint & cartilage support | Enhances repair | Mobility & recovery |
| Collagen signaling | Improves elasticity | Skin tightening & firmness |
✨ Additional Benefits
-
Increases metabolism & fat oxidation
-
Reduces formation of new fat cells
-
Improves collagen production
-
Supports cartilage & bone repair
-
Enhances joint mobility and flexibility
-
Anti-inflammatory benefits (arthritis support)
-
May prevent medication-related muscle loss
-
Does NOT affect blood sugar or insulin
⚠️ Possible Side Effects
Most users tolerate AOD-9604 well.
Reported effects may include:
-
Injection site irritation (redness, itching, swelling)
-
Headache or fatigue
-
Dizziness or cough
-
Chest tightness
-
Heart palpitations
-
Cold-like symptoms
Discontinue use if side effects escalate.
🚫 Contraindications
Do not use if:
-
Pregnant or breastfeeding
💧 Preparation
| Vial | Reconstitution |
|---|---|
| AOD-9604 — 5 mg | Mix with 3 mL (300 units) — Acetic Acid ONLY |
Use acetic acid, not bacteriostatic water, for proper solubility and stability.
💉 Dosing & Administration
-
Subcutaneous injection
-
5 days ON / 2 days OFF
-
Morning dosing for best results
-
Remain fasted ≥ 1 hour post-dose
(3–4 hours ideal for fat-burning protocols)
Steady-state typically reached after ~3 weeks.
Fat-loss effects accelerate after this phase.
📆 Cycle Duration Options
| Cycle | Duration | Notes |
|---|---|---|
| Typical | 8–12 weeks ON → 8–12 weeks OFF | Most common |
| Short | 6–8 weeks | Faster fat-loss push |
| Long | Up to 6 months | Maintenance style |
| Burst | 20 days ON / 10 days OFF | Popular micro-cycle |
🎯 Dosing Protocols
🟢 Standard Protocol (General Body Recomp / Long Cycles)
18 units = 300 mcg, once daily
| Timing | Instructions |
|---|---|
| Morning | Inject on empty stomach → stay fasted ≥ 1 hr (3–4 hours optimal) |
Steady, sustainable body-fat reduction & joint support
🔥 Weight Loss Protocol (Maximum Fat Loss / Short Cycles)
15 units = 250 mcg, twice daily
| Timing | Instructions |
|---|---|
| Morning | Fasted dose |
| Evening | ≥ 1 hour after dinner |
Targets stubborn fat + plateaus
Often paired with GLP-1s or Tesamorelin for enhanced results
🔗 Stacking Suggestions
| Goal | Stack | Why |
|---|---|---|
| Break plateaus | GLP-1s (Semaglutide/Tirzepatide/Retatrutide) | Appetite suppression + fat targeting |
| Joint & soft tissue repair | BPC-157, TB-500 | Regeneration + mobility |
| GH pathway support | CJC-1295 (No DAC), Ipamorelin, Sermorelin | Lean mass + recovery |
| Skin & elasticity | GHK-Cu | Collagen anchoring & tightness |
Most popular pairing:
AOD-9604 + Tirzepatide or Retatrutide
→ Blocks stubborn fat while appetite is controlled.
🧠 Quick Reference
-
Morning → fasted for best results
-
Expect visible changes after 3–6 weeks
-
Twice-daily dosing = fastest fat loss
-
Avoid carbohydrates immediately post-dose
-
Stack with GLP-1s to break plateaus